Atıf Formatları
Prevention of Scarring of Lung Parenchyma in COVID-19 Patients through Glucocorticoid Treatment
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

N. BOZKURT And A. N. YALÇIN, "Prevention of Scarring of Lung Parenchyma in COVID-19 Patients through Glucocorticoid Treatment," American Journal of Health Behavior , vol.47, no.1, pp.182-193, 2023

BOZKURT, N. And YALÇIN, A. N. 2023. Prevention of Scarring of Lung Parenchyma in COVID-19 Patients through Glucocorticoid Treatment. American Journal of Health Behavior , vol.47, no.1 , 182-193.

BOZKURT, N., & YALÇIN, A. N., (2023). Prevention of Scarring of Lung Parenchyma in COVID-19 Patients through Glucocorticoid Treatment. American Journal of Health Behavior , vol.47, no.1, 182-193.

BOZKURT, NURGÜL, And ATA NEVZAT YALÇIN. "Prevention of Scarring of Lung Parenchyma in COVID-19 Patients through Glucocorticoid Treatment," American Journal of Health Behavior , vol.47, no.1, 182-193, 2023

BOZKURT, NURGÜL And YALÇIN, ATA N. . "Prevention of Scarring of Lung Parenchyma in COVID-19 Patients through Glucocorticoid Treatment." American Journal of Health Behavior , vol.47, no.1, pp.182-193, 2023

BOZKURT, N. And YALÇIN, A. N. (2023) . "Prevention of Scarring of Lung Parenchyma in COVID-19 Patients through Glucocorticoid Treatment." American Journal of Health Behavior , vol.47, no.1, pp.182-193.

@article{article, author={NURGÜL BOZKURT And author={ATA NEVZAT YALÇIN}, title={Prevention of Scarring of Lung Parenchyma in COVID-19 Patients through Glucocorticoid Treatment}, journal={American Journal of Health Behavior}, year=2023, pages={182-193} }